RASSF4 and metabolic dysfunction-associated steatotic liver disease: In metabolic fatty liver disease (MASLD), fatty liver inflammation (MASH), and hepatocellular carcinoma (HCC), transcriptomic analyses revealed significantly downregulated RASSF4 expression.